Antidiabetic action of bezafibrate in a large observational database Academic Article uri icon

Overview

MeSH Major

  • Bezafibrate
  • Diabetes Mellitus, Type 2
  • Hypoglycemic Agents
  • Hypolipidemic Agents

abstract

  • Bezafibrate appears to have clinically important antidiabetic properties. Randomized controlled trials should be considered to assess the utility of bezafibrate in treating patients with diabetes or in preventing diabetes in high-risk patients.

publication date

  • April 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2660490

Digital Object Identifier (DOI)

  • 10.2337/dc08-1809

PubMed ID

  • 19131462

Additional Document Info

start page

  • 547

end page

  • 51

volume

  • 32

number

  • 4